Trial intelligence / Profile preview

Cholecalciferol in Hemodialysis Patients

NCT03602430Phase 3Completed

Sponsor
Ain Shams University
Start
Jul 2018
Primary completion
Sep 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Ain Shams University. Primary endpoint: Vitamin D level at 3 months. Started Jul 2018; status: completed.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT03602430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03602430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call